Мортен Хансен - Великие по собственному выбору
33. James D. Berkley and Nitin Nohria, “Amgen Inc.: Planning the Unplannable,” Harvard Business School, case study #9–492–052 (Boston: Harvard Business School Publishing, 1992), 11; Amy Tsao, “Amgen: Will Bigger be Better?” Business Week, January 2, 2002; David Stipp, “Biotech’s New Colossus: Move Over, Big Pharma. Amgen Boasts Better Growth,” Fortune, April 15, 2002; Frank DiLorenzo, “For Amgen, a Very Healthy Prognosis,” Business Week, August 10, 2004; Amgen Inc., Fiscal 1985, 1990, 1995 and 2000–2002 Annual Reports (Thousand Oaks, CA: Amgen Inc, 1985, 1990, 1995, and 2000–2002).
34. См. ниже обсуждение случая Genentech.
35. Geoffrey Smith, “Pay that was Justified-And Pay that Just Mystified,” Business Week, May 6, 1991, 92; Michael Brush, “Millions in the Bank, if They Don’t Stumble,” New York Times, March 3, 1997, 3.6; “Dane Miller-Biomet Inc (BMET): CEO Interview,” Wall Street Transcript, July 15, 2002; Biomet Inc., Fiscal 1982, 1987, 1992, 1997, and 2002 Annual Reports (Warsaw, IN: Biomet Inc., 1982, 1987, 1992, 1997, and 2002).
68
M. L. Mead: Scott & Stringfellow Inc., “Kirschner Medical Corporation – Company Report,” The Investext Group, February 17, 1989; J. H. Berg: J. C. Bradford & Co., “Kirschner Medical Corporation-Company Report,” The Investext Group, May 19, 1989, 1; Stan Hinden, “Kirschner Medical to Sell Surgical Lighting Division,” Washington Post, April 3, 1990, D01; Jason Zweig, “The Bone Doctor’s Plan,” Forbes, January 20, 1992, 92; Jessica Hall, “Torn between Two Bidders: Kirschner’s Enviable Dilemma,” Warfield’s Business Record, July 1, 1994, 3; Jessica Hall, “Kirschner Accepts Deal with Orthopedics Giant to End Seven-Week Bidding War,” Warfield’s Business Record, July 22, 1994, 1129. См. ниже обсуждение случая AMD.
69
Mary Jo Waits, et al., Beat the Odds (Tempe and Phoenix, AZ: Morrison Institute for Public Policy and Center for the Future of Arizona, 2006); Beat the Odds Institute, http://www.beattheoddsinstitute.org/overview/index.php.
70
Mary Jo Waits, et al., Beat the Odds (Tempe and Phoenix, AZ: Morrison Institute for Public Policy and Center for the Future of Arizona, 2006), 16, 25, 29, 36, 43; Arizona Indicators: A Program Managed by Morrison Institute for Public Policy, http://arizonaindicators.org/education.
71
Louise Kehoe, “How Immodesty Becomes a Silicon Valley Resident,” Financial Times, January 30, 1984, 10; “Advanced-Micro: Goal is to be No. 1 U. S. Integrated Circuit Producer by 1990,” Business Wire, September 11, 1984; Peter Dworkin, “Silicon Valley’s Vale of Tears,” U. S. News & World Report, March 2, 1987, 47; Jeffrey L. Rodengen, The Spirit of AMD: Advanced Micro Devices (Ft. Lauderdale, FL: Write Stuff Enterprises Inc., 1998), 82–83; Moody’s Investors Service and Mergent FIS Inc., 1973–1986 Moody’s OTC Industrial Manual (New York: Moody’s Investors Service, 1973–86). Advanced Micro Devices (AMD), Fiscal 1987 Annual Report (Sunnyvale, CA: Advanced Micro Devices, 1987).
72
Peter Dworkin, “Silicon Valley’s Vale of Tears,” U. S. News 6 World Report, March 2, 1987, 47; Dale Wettlaufer, “Interview with Vladi Catto,” Motley Fool, June 21, 1996; Douglas A. Irwin, “Trade Policies and the Semiconductor Industry,” National Bureau of Economic Research, January 1996, 27; Moody’s Investors Service and Mergent FIS Inc., 1973–1986 Moody’s OTC Industrial Manual (New York: Moody’s Investors Service, 1973–86). Advanced Micro Devices, Fiscal 1987 and 1997–2002 Annual Reports (Sunnyvale, CA: Advanced Micro Devices, 1987 and 1997–2002).
73
Roald Amundsen, The South Pole (McLean, VA: IndyPublish.com, 2009), “The First Account,” 213, 263; Roland Huntford, The Last Place on Earth (New York: Random House, 1999), 412–13, 419, 441–43, 466–67, 483–84.
74
“Hot Reception Seen Today for Genentech As First Gene-Splicing Firm to Go Public,” Wall Street Journal, October 14, 1980, 6; Nell Henderson, “Biotech Breakthrough Focuses on Heart Attacks,” Washington Post, October 12, 1986, HI; Charles McCoy, “Genentech’s New CEO Seeks Clean Slate – Levinson Takes Charge At Biotech Firm After Raab’s Ouster,” Wall Street Journal, July 12, 1995, B6; Bernadette Tansey, “Genentech Proves the Skeptics Wrong,” San Francisco Chronicle, December 21, 2003; Genentech Inc., Fiscal 1985 and 1991 Annual Reports (San Francisco: Genentech Inc., 1985 and 1991); Genentech Inc., http://www.gene.com.
75
David R. Olmos, “Genentech Ousts CEO over Conflict Question,” Los Angeles Times, July 11, 1985, Dl; Charles McCoy, “Genentech’s New CEO Seeks Clean Slate – Levinson Takes Charge At Biotech Firm After Raab’s Ouster,” Wall Street Journal, July 12, 1995, B6; Wayne Koberstein, “Youthful Maturity,” Pharmaceutical Executive, March 1999, 47; “Arthur D. Levenson-Genentech Inc. (GNE) CEO Interview,” Wall Street Transcript, January 26, 1998 (примечание: сохранена орфография названия статьи с ошибкой в фамилии Левинсона); данные по нетто-доходу взяты из Genentech Inc., Fiscal 1980–2008 Annual Reports (San Francisco: Genentech Inc., 1980–2008); Business Week Online, http://investing.businessweek.com/businessweek/research/stocks/people/person.asp?personld=234085&ticker=DNA: CN.
76
“Arthur D. Levenson – Genentech Inc. (GNE) CEO Interview,” Wall Street Transcript, January 26, 1998. (Примечание: сохранена орфография с ошибкой в фамилии Левинсона.)
77
Mimi Real and Robert Warren, A Revolution in Progress… A History of Intel to Date (Santa Clara, CA: Intel Corporate Communications Department, 1984), 17.
78
Gary Kissel, Poor Sailors' Airline (McLean, VA: Paladwr Press, 2002), viii, 21, 23, 69, 80, 116-17, 145, 171-72.
79
Gary Kissel, Poor Sailors’ Airline (McLean, VA: Paladwr Press, 2002), 118–19; Richard Curry, “The Skies of Texas,” New York Times, July 18, 1971; PSA Inc., Fiscal 1967 Annual Report (San Diego: PSA Inc., 1967).
80
“Love is Ammunition for a Texas Airline,” Business Week, June 26, 1971; Gary Kissel, Poor Sailors’ Airline (McLean, VA: Paladwr Press, 2002), 171.
81
Gary Kissel, Poor Sailors’ Airline (McLean, VA: Paladwr Press, 2002), 171–72; Lamar Muse, Southwest Passage: The Inside Story of Southwest Airlines’ Formative Years (Austin, TX: Eakin Press, 2002), 84; Christopher H. Lovelock, “Southwest Airlines (A),” Harvard Business School, case study #9–575–060 (Boston: Harvard Business School Publishing, 1985).
82
“USAir Completes Takeover of Pacific Southwest,” Washington Post, May 30, 1987.
83
Анализ по патентной политике опирается на три источника: 1) United States Patent and Trademark Office (USPTO) Official Database, 2) Dialog Research Services и 3) анализ базы данных по патентам и обращениям к ним профессора Ясита Сингха, Бизнес-школа INSEAD: “USPTO Patent Full-Text and Image Database,” United States Patent and Trademark Office, http://www.uspto.gov/; “New Biotechnology Companies,” Science, February 11, 1983; “Corporate Chronology,” Genentech Inc., www.gene.com/gene/about/corporate/history/timeline.html.
84
Noreen Seebacher, “Stryker Products: Just What the Doctor Ordered,” Detroit News, May 6, 1991, 3F; Barry Stavro, “The Hipbone’s Connected to the Bottom Line,” Forbes, December 3, 1984; Ron Winslow, “As Marketplace Shifts, U. S. Surgical Needs Patching Up,” Wall Street Journal, February 18, 1994; United States Surgical Corporation, Fiscal 1987 Annual Report (Norwalk, CT: United States Surgical Corporation, 1987); Christine Shenot, “U. S. Surgical Innovations Are Cut Above Rest,” Investor’s Daily, March 5, 1991, 36; “Corporate Critics Confidential: Medical Technology,” Wall Street Transcript, February 11, 1991.
85
“Stakes are Large in Battle for Microprocessor Market,” Globe and Mail, November 24, 1980, B5; “Section Three: The Great Dark Cloud Falls: IBM’s Choice,” CPU Shack, http://www.cpushack.com/CPU/cpu3.html; George W. Cogan and Robert A. Burgelman, “Intel Corporation (A): The DRAM Decision,” Graduate School of Business, Stanford University, case study #S-BP-256 (Palo Alto, CA: Graduate School of Business, Stanford University, 1989), 9–10; Ashish Nanda and Christopher A. Bartlett, “Intel Corporation – Leveraging-Capabilities for Strategic Renewal,” Harvard Business School, case study #9–394–141 (Boston: Harvard Business School Publishing, 1994), 3; Aditya P. Mathur, Introduction to Microprocessor, 3rd ed. (Noida, India: Tata McGraw-Hill, 1989), 111; “History: 50 Years of Industry Leadership,” National Semiconductor, www.national.com/analog/company/history; “Intel 8086,” Webster’s Online, www.websters-online-dictionary.org/definitions/Intel+8086?cx=partner-Pub-0939450753529744%3Av0qd01-tdlq&cof=FORID%3A9&ie=UTF-8&q=Intel+8086&sa=Search#922; Andrew Pollack, “Intel Offers a 32-Bit Microprocessor,” New York Times, October 17, 1985; Brenton R. Schlender, “Fast Game: Intel Introduces a Chip Packing Huge Power and Wide Ambitions,” Wall Street Journal, February 28, 1989.
86
Gerard J. Tellis and Peter N. Golder, Will and Vision (New York: McGraw-Hill, 2002), xiii-xv, 43, 46, 290–92.
87
Gene Bylinsky, “How Intel Won Its Bet on Memory Chips,” Fortune, November 1973, 147, 184, 189; Intel Corporation, Fiscal 1971 Annual Report (Santa Clara, CA: Intel Corporation, 1971).
88
Gene Bylinsky, “How Intel Won Its Bet on Memory Chips,” Fortune, November 1973, 147.
89
Gene Bylinsky, “How Intel Won Its Bet on Memory Chips,” Fortune, November 1973, 184.
